Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
基本信息
- 批准号:9893801
- 负责人:
- 金额:$ 250万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-15 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Active immunityAffectAnimal ModelAnimalsAntibiotic ResistanceAntibioticsAntibodiesAntigensAntimicrobial ResistanceArchivesAttenuatedB-LymphocytesBacteriaBacterial Antibiotic ResistanceBacterial AntibodiesBacterial InfectionsBioterrorismBlood CirculationCampylobacter jejuniCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeChildClinicalClinical MedicineClinical TrialsClostridium difficileColitisConjugate VaccinesCountryDataDeveloping CountriesDevelopmentDiarrheaDiseaseDrug resistanceDrug-resistant CampylobacterDysenteryElderlyEngineeringEnteralEpidemiologyFlagellinFutureGastroenteritisGenesGermHaemophilus influenzae type bHemorrhagic colitisHospitalsHumanImmuneImmune responseImmune systemImmunocompromised HostImmunologicsImpairmentIndividualInfantInfectionInfection preventionInvadedInvestigational New Drug ApplicationKlebsiella pneumoniaeLinkMeasurementMediatingMobile Genetic ElementsMorbidity - disease rateMulti-Drug ResistanceNosocomial InfectionsOralPassive ImmunityPhase I Clinical TrialsPlasmidsPolysaccharide-KPopulationPreventionPrevention strategyPreventiveProbioticsPropertyPseudomonas aeruginosaPublic HealthR-factorRecombinantsResearchResearch PersonnelResearch Project GrantsResearch ProposalsResistanceRisk FactorsRunningSaccharomycesSafetySalmonellaSalmonella VaccinesSalmonella paratyphiSalmonella typhiSalmonella typhimuriumSavingsSerotypingSerumShigellaShigella dysenteriaeSpecimenSpeedStreptococcus pneumoniaeT-LymphocyteThinnessToxinTranslational ResearchTyphoid FeverUnited States Food and Drug AdministrationVaccinatedVaccinationVaccinesYeastsagedantimicrobialbiodefensecross reactivitydiarrheal diseaseenteric infectionenteric pathogenenterotoxigenic Escherichia coliexperiencefungusgut colonizationhealth care settingsimmunogenicityimprovedinnovationinterestmicroorganismmortalitynon-typhoidal Salmonellanovel vaccinesoral vaccinepassive antibodiespathogenpathogenic bacteriapre-clinicalpressurepreventresistant Shigellatoolvector vaccine
项目摘要
CETR OVERALL ABSTRACT
Widespread antimicrobial resistance (AMR), both in the USA and globally, has made it increasingly difficult to
treat enteric and invasive nosocomial bacterial infections that were previously responsive to antimicrobials.
Among the most important enteric bacterial pathogens that cause severe clinical disease and death if they
cannot be treated with effective antibiotics are ones that cause diarrhea, dysentery or enteric fever. Some
bacterial enteric pathogens are epidemiologically emerging or re-emerging, e.g.: multi-drug resistant H58
lineage of Salmonella Typhi; S. Paratyphi A; multi-drug resistant Shigella; drug-resistant Campylobacter jejuni
and Clostridium difficile. A few bacterial enteropathogens are of special interest from the civilian biodefense
perspective, as they have been used by nefarious individuals to promulgate bioterror (non-typhoidal
Salmonella [NTS]), or have properties that suit them to such a purpose (Shigella dysenteriae 1). Two of the
most important opportunistic drug-resistant bacterial pathogens that cause invasive infections in compromised
hosts are Klebsiella pneumoniae and Pseudomonas aeruginosa. Vaccines and other preventives against these
pathogens can ameliorate the AMR problem by preventing clinical disease, thereby precluding the need to
administer antibiotics and relieving selection pressure. The five projects described in this Center of Excellence
for Translational Research (CETR) proposal, bonded by the theme “Active Vaccination and Passive Antibody
Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens”, will undertake translational
research towards developing the following countermeasures to prevent disease caused by important multi-drug
resistant bacterial pathogens: an improved Shigella live vector vaccine consisting of 6 attenuated strains of key
serotypes, each expressing protective antigens to prevent clinical illness caused by ETEC, as well as Shigella
(Project 1); engineered attenuated NTS strains representing serogroups B, C1, C2 & D to serve as a
multivalent broadly protective live oral vaccine (Project 2); a conjugate vaccine consisting of O polysaccharides
of K. pneumoniae serotypes O1, O2, O3 & O5, representing the vast majority of invasive isolates, linked to
flagellin type A or B of P. aeruginosa, to prevent invasive disease (Project 3); the probiotic yeast
Saccharomyces boulardii engineered to secrete antibodies against K. pneumoniae fimbriae that mediate
intestinal colonization, thereby diminishing a major risk factor (colonization) for invasive disease (Project 3);
recombinant S. boulardii that secrete antibodies directed against C. difficile toxins and somatic antigens or
against flagellin of C. jejuni, administered orally to inhibit gut colonization and prevent diarrheal disease
(Project 4); a compendium of immune response measurements to Salmonella serovars to identify correlates of
protection and guide development of broadly protective live oral Salmonella vaccines (Project 5). Translational
research will advance these countermeasures to where Investigational New Drug Applications (IND) can be
prepared to initiate Phase 1 clinical trials.
CETR总体摘要
在美国和全球范围内广泛存在的抗菌素耐药性 (AMR) 使得抗菌药物耐药性变得越来越困难
治疗以前对抗菌药物有反应的肠道和侵入性医院细菌感染。
最重要的肠道细菌病原体之一,如果它们存在,会导致严重的临床疾病和死亡
无法用有效抗生素治疗的疾病是引起腹泻、痢疾或肠热病的疾病。一些
细菌性肠道病原体在流行病学上正在出现或重新出现,例如:多重耐药性 H58
伤寒沙门氏菌谱系;甲型副伤寒沙门氏菌;多重耐药志贺氏菌;耐药空肠弯曲菌
和艰难梭菌。民用生物防御特别关注一些细菌性肠道病原体
的观点,因为它们已被邪恶的个人用来传播生物恐怖(非伤寒
沙门氏菌 [NTS]),或具有适合此类目的的特性(痢疾志贺氏菌 1)。其中两个
最重要的机会性耐药细菌病原体,可在受损人群中引起侵袭性感染
宿主是肺炎克雷伯菌和铜绿假单胞菌。疫苗和其他预防措施
病原体可以通过预防临床疾病来改善 AMR 问题,从而无需
施用抗生素并缓解选择压力。该卓越中心描述的五个项目
转化研究(CETR)提案,以“主动疫苗接种和被动抗体”为主题
预防多重耐药细菌病原体引起的疾病的策略”,将进行转化
研究制定以下对策以预防重要的多种药物引起的疾病
耐药细菌病原体:一种改良的志贺氏菌活载体疫苗,由 6 种关键减毒菌株组成
每种血清型都表达保护性抗原,以预防 ETEC 以及志贺氏菌引起的临床疾病
(项目1);设计了代表血清群 B、C1、C2 和 D 的减毒 NTS 菌株,作为
多价广泛保护性口服活疫苗(项目2);由 O 多糖组成的结合疫苗
肺炎克雷伯菌血清型 O1、O2、O3 和 O5 代表绝大多数侵入性分离株,与
铜绿假单胞菌 A 型或 B 型鞭毛蛋白,用于预防侵袭性疾病(项目 3);益生菌酵母
布拉氏酵母菌经过改造,可分泌针对肺炎克雷伯菌菌毛的抗体,从而介导
肠道定植,从而减少侵袭性疾病的主要危险因素(定植)(项目 3);
重组布拉氏酵母菌,其分泌针对艰难梭菌毒素和体细胞抗原的抗体,或
对抗空肠弯曲菌鞭毛蛋白,口服可抑制肠道定植并预防腹泻病
(项目4);对沙门氏菌血清型的免疫反应测量概要,以确定相关性
保护并指导开发具有广泛保护性的口服沙门氏菌活疫苗(项目 5)。翻译性
研究将把这些对策推进到研究性新药申请 (IND) 的阶段
准备启动1期临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Myron Max Levine其他文献
Myron Max Levine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Myron Max Levine', 18)}}的其他基金
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
- 批准号:
10584474 - 财政年份:2019
- 资助金额:
$ 250万 - 项目类别:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
- 批准号:
10364708 - 财政年份:2019
- 资助金额:
$ 250万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
9232995 - 财政年份:2014
- 资助金额:
$ 250万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
9447098 - 财政年份:2014
- 资助金额:
$ 250万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
8642251 - 财政年份:2014
- 资助金额:
$ 250万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
8803292 - 财政年份:2014
- 资助金额:
$ 250万 - 项目类别:
University of Maryland Development Research Program
马里兰大学发展研究计划
- 批准号:
8233368 - 财政年份:2011
- 资助金额:
$ 250万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 250万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 250万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 250万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 250万 - 项目类别:
Grant-in-Aid for Early-Career Scientists